Testing for RET
Welcome to our webinar series on RET. We are excited to share with you the latest research and information on RET-driven cancers. Select a webinar below to learn more about the featured speaker and watch a 1-hr webinar.
Molecular Testing in Thyroid Cancer: Why It Matters
Lori J. Wirth, MD
Genetic and Genomic Testing in Thyroid Cancer: Why, when, who and how?
Bryan McIver, MD, PhD
Molecular Testing in Thyroid Cancer: Emerging Biomarkers RET and NTRK
Ezra E.W. Cohen, MD, FRCPSC, FASCO
Thyroid Carcinomas with RET? You bet!
Justin Bishop MD
Selected Thyroid Follicular Lesions
Lester D. R. Thompson, MD
RET Fusions in Thyroid Cancer:
Prevalence, Histologic Features, Detection
Yuri E. Nikiforov, MD, PhD
Testing for RET is provided by Lighthouse, a Celerity Biosciences Subsidy, and Funded by Loxo Oncology at Lilly